Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Public ClinicalTrials.gov record NCT00021372. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Study of Paclitaxel and Estramustine Phosphate in Patients With Relapsed Non-Hodgkin's Lymphoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combining paclitaxel and estramustine in treating patients who have relapsed or refractory non-Hodgkin's lymphoma.
Study identification
- NCT ID
- NCT00021372
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 25 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 1996 (Type not available)
- Primary completion
- Sep 2006 (Actual)
- Completion
- Sep 2006 (Actual)
- Last update posted
- Jul 10, 2013
1996 – 2006
United States locations
- U.S. sites
- 17
- U.S. states
- 2
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hunterdon Regional Cancer Center | Flemington | New Jersey | 08822 | — |
| Kimball Medical Center | Lakewood | New Jersey | 08701 | — |
| South Jersey Regional Cancer Center | Millville | New Jersey | 08332 | — |
| Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County | Mount Holly | New Jersey | 08060 | — |
| Riverview Medical Center - Booker Cancer Center | Red Bank | New Jersey | 07701 | — |
| Community Medical Center | Toms River | New Jersey | 08755 | — |
| St. Francis Medical Center | Trenton | New Jersey | 08629 | — |
| Bon Secours-Holy Family Health System | Altoona | Pennsylvania | 16602 | — |
| Delaware County Memorial Hospital | Drexel Hill | Pennsylvania | 19026 | — |
| Pinnacle Health Hospitals | Harrisburg | Pennsylvania | 17105-8700 | — |
| Conemaugh Memorial Hospital | Johnstown | Pennsylvania | 15905 | — |
| Saint Mary Regional Center | Langhorne | Pennsylvania | 19047 | — |
| North Penn Hospital | Lansdale | Pennsylvania | 19446-1200 | — |
| Paoli Memorial Hospital | Paoli | Pennsylvania | 19301-1792 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
| Pottstown Memorial Regional Cancer Center | Pottstown | Pennsylvania | 19464 | — |
| Reading Hospital and Medical Center | Reading | Pennsylvania | 19612-6052 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00021372, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 10, 2013 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00021372 live on ClinicalTrials.gov.